NASDAQ:GGR charts & data provided by TradingView

Latest Insights on GGR

Investors are worried. But stock momentum tells us that they shouldn't be. Here's why the time to aggressively invest in the stock market is now. S&P 500 Signals Stocks in Safe Zone Are Gaining Potential
by Michael Carr November 27, 2017 Investing, Stocks
Investors are worried. But stock momentum tells us that they shouldn't be. Here's why the time to aggressively invest in the stock market is now.
Guide to Analyzing Insider Sentiment: Tiffany & Co. Example
by Optin November 15, 2017 Adventure Capitalist
Last week, we booked a quick +52.4% profit on AeroVironment (AVAV). I say “quick” because AVAV was in our Adventure Capitalist portfolio for less than seven months. AeroVironment designs, develops, produces, supports and operates unmanned aircraft systems (UAS) and efficient energy systems (EES) in the U.S. and internationally. Through intensive research, I found that this company was the […]
Middle East Meltdown and a Bombshell from Germany!
by Optin November 8, 2017 E-Wave Trader
If anyone has doubts that the cycles of war are indeed ramping up, just as Larry Edelson predicted several years ago, the latest headlines out of the Middle East should be very convincing. As you’ve no doubt seen reported, there was a royal shakedown in Saudi Arabia over the weekend that had more drama than […]
What’s so interesting (and dangerous) is that it’s not mortgage debt, but all the nonhousing debt that’s leading the charge this time. Rising Debt Spells ‘Warning!’ for This Bull Market
by Jeff Yastine November 7, 2017 U.S. Economy
What’s so interesting (and dangerous) is that it’s not mortgage debt, but all the nonhousing debt that’s leading the charge this time.
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases. Gene Editing: The Cure for Every Disease?
by Ian Dyer November 2, 2017 Investment Opportunities
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

Share This